Multicenter Evaluation of the QIAstat-Dx Respiratory Panel for Detection of Viruses and Bacteria in Nasopharyngeal Swab Specimens-Reference-Cited by-同舟云学术

Multicenter Evaluation of the QIAstat-Dx Respiratory Panel for Detection of Viruses and Bacteria in Nasopharyngeal Swab Specimens

Published:2020-04-23 Issue:5 Volume:58 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Leber Amy L.¹,Lisby Jan Gorm²,Hansen Glen³,Relich Ryan F.⁴,Schneider Uffe Vest²^ORCID,Granato Paul⁵^ORCID,Young Stephen⁶,Pareja Josep⁷,Hannet Irene⁷

Affiliation:

1. Nationwide Children’s Hospital, Columbus, Ohio, USA

2. University of Copenhagen Hvidovre Hospital, Hvidovre, Denmark

3. Hennepin County Medical Center, Minneapolis, Minnesota, USA

4. Indiana University School of Medicine, Indianapolis, Indiana, USA

5. Laboratory Alliance of Central New York, Liverpool, New York, USA

6. TriCore Reference Laboratories, Albuquerque, New Mexico, USA

7. STAT-DX Life (now a Qiagen company), Barcelona, Spain

Abstract

The QIAstat-Dx Respiratory Panel (QIAstat-Dx RP) is a multiplex in vitro diagnostic test for the qualitative detection of 20 pathogens directly from nasopharyngeal swab (NPS) specimens. The assay is performed using a simple sample-to-answer platform with results available in approximately 69 min. The pathogens identified are adenovirus, coronavirus 229E, coronavirus HKU1, coronavirus NL63, coronavirus OC43, human metapneumovirus A and B, influenza A, influenza A H1, influenza A H3, influenza A H1N1/2009, influenza B, parainfluenza virus 1, parainfluenza virus 2, parainfluenza virus 3, parainfluenza virus 4, rhinovirus/enterovirus, respiratory syncytial virus A and B, Bordetella pertussis , Chlamydophila pneumoniae , and Mycoplasma pneumoniae .

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.00155-20

Reference24 articles.

1. The annual impact of seasonal influenza in the US: Measuring disease burden and costs

2. The Economic Burden of Non–Influenza-Related Viral Respiratory Tract Infection in the United States

3. Impact of a Rapid Respiratory Panel Test on Patient Outcomes

4. Antimicrobial stewardship for hospitalized patients with viral respiratory tract infections

5. Impact of Early Detection of Respiratory Viruses by Multiplex PCR Assay on Clinical Outcomes in Adult Patients

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical performance of the Roche Cobas Liat SARS-CoV-2 & influenza A/B assay: A systematic review and meta-analysis;Journal of Clinical Virology;2024-10

2. Development of a dual-Raman signal lateral flow immunoassay with self-assembling nanogapped SERS tags for the simultaneous monitoring of respiratory bacteria and virus;Sensors and Actuators B: Chemical;2024-10

3. Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel for detection of pathogens in nasopharyngeal and lower respiratory tract specimens;Diagnostic Microbiology and Infectious Disease;2024-09

4. Performance comparison of three commercial multiplex molecular panels for respiratory viruses at a South African academic hospital;African Journal of Laboratory Medicine;2024-08-20

5. Towards improved point-of-care (POC) testing for patients with suspected sepsis: POC tests for host biomarkers and possible microbial pathogens;Expert Review of Molecular Diagnostics;2024-08-13